| $350M | ||
| $172M | ||
| $127M | ||
| $109M | ||
| $107M | ||
| $100M |
Buys | $1,744,000 | 21 | 100 |
Sells | $0 | 0 | 0 |
| Siokas Grigorios | Chief Executive Officer | 20 | $1.7M | 0 | $0 | $1.7M |
| Terzis Georgios | Chief Financial Officer | 1 | $42,000 | 0 | $0 | $42,000 |
Cosmos Health Inc. functions as a vertically integrated pharmaceutical firm, providing its own line of branded and generic medicines, nutraceuticals, non-prescription drugs, healthcare and infant products, medical devices, and various other goods. These are distributed via its established channels and an e-commerce marketplace. The company actively seeks, obtains, develops, and commercializes solutions designed to improve patients' well-being and health outcomes. Supporting these operations, it maintains distribution centers in both Greece and the United Kingdom, alongside a dedicated warehousing facility. Its clientele includes wholesale pharmaceutical distributors and independent retail pharmacies. Cosmos Health Inc. was established in 2009 and has its headquarters in Chicago, Illinois.
Over the last 12 months, insiders at Cosmos Health Inc. have bought $1.74M and sold $0 worth of Cosmos Health Inc. stock.
On average, over the past 5 years, insiders at Cosmos Health Inc. have bought $2.07M and sold $140,934 worth of stock each year.
Highest buying activity among insiders over the last 12 months: Siokas Grigorios (Chief Executive Officer) — $1.7M. Terzis Georgios (Chief Financial Officer) — $42,000.
The last purchase of 349,825 shares for transaction amount of $70,000 was made by Siokas Grigorios (Chief Executive Officer) on 2026‑07‑30.
| 2026-07-30 | Siokas Grigorios | Chief Executive Officer | 349,825 0.5635% | $0.20 | $70,000 | +9.85% | ||
| 2026-07-29 | Siokas Grigorios | Chief Executive Officer | 766,284 1.2344% | $0.18 | $140,000 | +19.79% | ||
| 2026-06-16 | Terzis Georgios | Chief Financial Officer | 168,135 0.2708% | $0.25 | $42,000 | -12.77% | ||
| 2026-06-11 | Siokas Grigorios | Chief Executive Officer | 218,447 0.3643% | $0.21 | $45,000 | +5.80% | ||
| 2026-06-10 | Siokas Grigorios | Chief Executive Officer | 701,447 1.1699% | $0.23 | $160,000 | -4.47% | ||
| 2026-02-12 | Siokas Grigorios | Chief Executive Officer | 388,532 1.427% | $0.37 | $145,000 | -25.04% | ||
| 2026-02-11 | Siokas Grigorios | Chief Executive Officer | 291,262 1.0697% | $0.41 | $120,000 | -31.43% | ||
| 2026-01-23 | Siokas Grigorios | Chief Executive Officer | 90,325 0.3317% | $0.50 | $45,000 | -40.28% | ||
| 2026-01-20 | Siokas Grigorios | Chief Executive Officer | 353,321 1.2976% | $0.50 | $175,000 | -39.39% | ||
| 2026-01-14 | Siokas Grigorios | Chief Executive Officer | 493,495 1.8125% | $0.45 | $220,000 | -32.56% | ||
| 2026-01-12 | Siokas Grigorios | Chief Executive Officer | 113,185 0.4157% | $0.50 | $57,000 | -40.03% | ||
| 2026-01-08 | Siokas Grigorios | Chief Executive Officer | 156,190 0.5736% | $0.52 | $81,000 | -41.30% | ||
| 2026-01-07 | Siokas Grigorios | Chief Executive Officer | 124,880 0.4605% | $0.52 | $65,000 | -41.19% | ||
| 2026-01-06 | Siokas Grigorios | Chief Executive Officer | 133,953 0.4983% | $0.54 | $72,000 | -43.01% | ||
| 2025-12-19 | Siokas Grigorios | Chief Executive Officer | 88,314 0.3243% | $0.49 | $43,000 | -35.90% | ||
| 2025-12-15 | Siokas Grigorios | Chief Executive Officer | 168,472 0.6249% | $0.42 | $70,000 | -23.89% | ||
| 2025-11-28 | Siokas Grigorios | Chief Executive Officer | 76,360 0.2804% | $0.64 | $49,000 | -49.19% | ||
| 2025-11-25 | Siokas Grigorios | Chief Executive Officer | 55,732 0.1897% | $0.63 | $35,000 | -47.09% | ||
| 2025-11-21 | Siokas Grigorios | Chief Executive Officer | 56,080 0.1881% | $0.68 | $38,000 | -50.74% | ||
| 2025-11-20 | Siokas Grigorios | Chief Executive Officer | 51,315 0.1721% | $0.62 | $32,000 | -46.28% |
| Siokas Grigorios | Chief Executive Officer | 14597917 26.8204% | $3.99M | 61 | 36 | <0.0001% |
| Terzis Georgios | Chief Financial Officer | 2235398 4.107% | $610,710.73 | 2 | 0 | +6% |
| MAVROGIANNIS VASILEIOS | 10 percent owner | 9700227 17.822% | $2.65M | 2 | 8 | |
| DRAKOPOULOS PANAGIOTIS | CEO | 8758561 16.0919% | $2.39M | 0 | 7 | |
| GOLDSTEIN PETER | 157100 0.2886% | $42,919.72 | 1 | 0 |
| Increased Positions | 11 | +52.38% | 358,688 | +29.49% |
| Decreased Positions | 7 | -33.33% | 143,149 | -11.77% |
| New Positions | 3 | New | 39,073 | New |
| Sold Out Positions | 4 | Sold Out | 26,190 | Sold Out |
| Total Postitions | 25 | +19.05% | 1M | +17.72% |
| Blackrock, Inc. | $138.00 | 0.72% | 267,797 | 0 | 0% | 2025-09-30 |
| Vanguard Group Inc | $121.00 | 0.64% | 235,742 | +100,908 | +74.84% | 2025-09-30 |
| Citadel Advisors Llc | $116.00 | 0.61% | 225,507 | +128,776 | +133.13% | 2025-09-30 |
| Geode Capital Management, Llc | $102.00 | 0.54% | 198,684 | +7,124 | +3.72% | 2025-09-30 |
| Renaissance Technologies Llc | $48.00 | 0.25% | 92,800 | +92,800 | New | 2025-09-30 |
| Xtx Topco Ltd | $34.00 | 0.18% | 65,493 | +28,791 | +78.44% | 2025-09-30 |
| State Street Corp | $13.00 | 0.07% | 24,743 | 0 | 0% | 2025-09-30 |
| Northern Trust Corp | $11.00 | 0.06% | 20,554 | 0 | 0% | 2025-09-30 |
| Susquehanna International Group, Llp | $11.00 | 0.06% | 20,514 | +20,514 | New | 2025-09-30 |
| Stonex Group Inc. | $10.00 | 0.05% | 19,300 | +19,300 | New | 2025-09-30 |